Ignite Creation Date:
2025-12-24 @ 9:38 PM
Ignite Modification Date:
2026-02-20 @ 4:44 PM
Study NCT ID:
NCT01423032
Status:
COMPLETED
Last Update Posted:
2011-08-25
First Post:
2011-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)
Sponsor:
WiSP Wissenschaftlicher Service Pharma GmbH
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
WISP_RI05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None